Non-Segmental Vitiligo Research Study (60 Weeks)

Adults aged 18-65 with a diagnosis of non-segmental vitiligo (loss of skin pigment) for at least 3 months, may qualify to participate. Individuals must have 4%-50% loss of skin pigment on the body and some involvement on the face. At least one active lesion must be present at the time of study entry.

Participants will receive investigational oral medication (active study drug) or placebo during the dose-ranging period. Phototherapy may be included as part of the treatment, during the extension period. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 60 weeks and involve up to 19 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Vitiligo
Register Now!

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more